RON2L1

TgRON2L1 is a Toxoplasma gondii rhoptry neck protein that functions as a stage-specific component of the moving junction during host cell invasion, forming a high-affinity functional complex with the AMA-family protein TgAMA4 at the parasite-host interface (PMID:26712012, PMID:36693095). High-resolution crystal structures of the TgAMA4-RON2L1 complex reveal an assembly mechanism distinct from the canonical AMA1-RON2 pair: TgAMA4 lacks both the deep surface groove and the key surface loop that govern RON2 ligand-binding selectivity, defining a structurally divergent AMA-RON module (PMID:26712012). Rather than operating in tachyzoites, the TgAMA4-RON2L1 pair is deployed in sporozoites and bradyzoites, and is required for cyst burden during chronic infection while being dispensable for the acute phase (PMID:26712012, PMID:36693095). The complex also serves as a redundant invasion module, upregulated to support residual host cell invasion when AMA1 is disrupted (PMID:24934579), and immunization with the assembled complex selectively targets the chronic bradyzoite stage (PMID:36693095).

1. 2014 Medium

   Whether the AMA1-RON2 moving-junction machinery is uniquely essential was unknown; disrupting AMA1 revealed that paralogous AMA-RON pairs including RON2L1 are upregulated to sustain residual invasion, establishing functional plasticity and redundancy at the moving junction.

   Evidence Reverse genetics (AMA1 gene disruption) with invasion assays in T. gondii

   PMID:24934579

   Open questions at the time

   • Does not define the direct binding partner or structural basis of the RON2L1 complex
   • Does not establish which life stage naturally uses RON2L1
2. 2015 High

   It was unclear whether RON2L1 engaged an AMA partner and by what architecture; co-crystallization with TgAMA4 and mutagenesis showed a high-affinity complex assembled without the canonical groove and loop that define AMA1-RON2 selectivity, establishing a mechanistically distinct AMA-RON pairing.

   Evidence Co-crystallization, X-ray crystallography, alanine scanning mutagenesis and binding assays in T. gondii

   PMID:26712012

   Open questions at the time

   • Structure does not establish the in vivo invasion role of the complex
   • Cellular localization dynamics at the junction not resolved by the structure
3. 2015 Medium

   The developmental context of the AMA4-RON2L1 pair was undefined; phylogenetic and expression analysis placed TgAMA4 with Plasmodium MAEBL proteins and in sporozoites, framing RON2L1 as part of a co-evolved, stage-specific alternative to the tachyzoite AMA1-RON2 machinery.

   Evidence Phylogenetic analysis and expression profiling with structural/biochemical characterization in T. gondii

   PMID:26712012

   Open questions at the time

   • Correlative expression does not prove functional requirement in sporozoites
   • Does not test the pair's role in bradyzoites
4. 2023 High

   Whether the AMA4-RON2L1 complex is functionally required in vivo was unknown; genetic disruption of AMA4 showed it is needed for cyst burden during chronic infection but dispensable for acute infection, establishing the complex as the bradyzoite-stage moving-junction module.

   Evidence Genetic disruption of AMA4 with cyst burden assays and functional characterization in T. gondii

   PMID:36693095

   Open questions at the time

   • Direct RON2L1 loss-of-function phenotype not separately reported here
   • Mechanism of stage-specific expression switching not defined
5. 2023 Medium

   Whether the stage-specific complex could be exploited therapeutically was open; immunization with the AMA4-RON2L1 complex selectively targeted the chronic bradyzoite form compared to AMA1-RON2, validating it as a stage-specific vaccine target.

   Evidence Mouse immunization and challenge experiments with cyst burden quantification in T. gondii

   PMID:36693095

   Open questions at the time

   • Durability and mechanism of protective immunity not defined
   • Single-lab in vivo model

• How RON2L1 is trafficked to and inserted into the host cell membrane at the moving junction, and the molecular basis of its stage-restricted deployment, remain uncharacterized in the available corpus.
• No mechanism for stage-specific transcriptional/translational control
• Membrane insertion and rhoptry secretion dynamics of RON2L1 not defined